Anne Marie Falk

Array ( [id] => 6877000 [patent_doc_number] => 20010007153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'SOLID CHIMERIC ORGANS, ANIMAL MODELS HAVING SAME, PROCESS FOR PREPARING SAME, NON-TUMORIGENIC IMMORTALIZED HUMAN CELL LINES, SUSCEPTIBLE CELLS AND CYTOPATHIC MAMMALIAN VIRUSES' [patent_app_type] => new-utility [patent_app_number] => 08/876635 [patent_app_country] => US [patent_app_date] => 1997-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14373 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007153.pdf [firstpage_image] =>[orig_patent_app_number] => 08876635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6051881 [patent_doc_number] => 20020170076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'USE OF FLP RECOMBINASE IN MICE' [patent_app_type] => new [patent_app_number] => 08/866279 [patent_app_country] => US [patent_app_date] => 1997-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12889 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20020170076.pdf [firstpage_image] =>[orig_patent_app_number] => 08866279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4148297 [patent_doc_number] => 06106827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Method of producing genetically modified astrocytes and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/862438 [patent_app_country] => US [patent_app_date] => 1997-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 6586 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/106/06106827.pdf [firstpage_image] =>[orig_patent_app_number] => 862438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1255486 [patent_doc_number] => 06667034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-23 [patent_title] => 'METHODS FOR REGULATING THE SPECIFIC LINEAGES OF CELLS PRODUCED IN A HUMAN HEMATOPOIETIC CELL CULTURE, METHODS FOR ASSAYING THE EFFECT OF SUBSTANCES ON LINEAGE-SPECIFIC CELL PRODUCTION, AND CELL COMPOSITIONS PRODUCED BY THESE CULTURES' [patent_app_type] => B2 [patent_app_number] => 08/857594 [patent_app_country] => US [patent_app_date] => 1997-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22403 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667034.pdf [firstpage_image] =>[orig_patent_app_number] => 08857594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181293 [patent_doc_number] => 06150160 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Compositions and methods of use of mammalian retrotransposons' [patent_app_type] => 1 [patent_app_number] => 8/847844 [patent_app_country] => US [patent_app_date] => 1997-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 18 [patent_no_of_words] => 34818 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150160.pdf [firstpage_image] =>[orig_patent_app_number] => 847844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596136 [patent_doc_number] => 06384202 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Cell-specific active compounds regulated by the cell cycle' [patent_app_type] => B1 [patent_app_number] => 08/793109 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22497 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384202.pdf [firstpage_image] =>[orig_patent_app_number] => 08793109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185158 [patent_doc_number] => 06159948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Therapeutic and drug screening methods for the treatment and prevention of neuronal disease' [patent_app_type] => 1 [patent_app_number] => 8/844693 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21671 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159948.pdf [firstpage_image] =>[orig_patent_app_number] => 844693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3952813 [patent_doc_number] => 05955645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Thrombin receptor deficient transgenic mice' [patent_app_type] => 1 [patent_app_number] => 8/847953 [patent_app_country] => US [patent_app_date] => 1997-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 9 [patent_no_of_words] => 13433 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955645.pdf [firstpage_image] =>[orig_patent_app_number] => 847953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4072058 [patent_doc_number] => 06069133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Targeted delivery of genes encoding interferon' [patent_app_type] => 1 [patent_app_number] => 8/819238 [patent_app_country] => US [patent_app_date] => 1997-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 10929 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069133.pdf [firstpage_image] =>[orig_patent_app_number] => 819238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4412442 [patent_doc_number] => 06310270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Endothelial NOS knockout mice and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/818082 [patent_app_country] => US [patent_app_date] => 1997-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 53 [patent_no_of_words] => 20757 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310270.pdf [firstpage_image] =>[orig_patent_app_number] => 818082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951387 [patent_doc_number] => 20020006660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'GENETICALLY-MODIFIED NEURAL PROGENITORS AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 08/810315 [patent_app_country] => US [patent_app_date] => 1997-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9238 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006660.pdf [firstpage_image] =>[orig_patent_app_number] => 08810315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4348280 [patent_doc_number] => 06284880 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Chicken embryo lethal orphan (CELO) virus GAM-1' [patent_app_type] => 1 [patent_app_number] => 8/750180 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 16826 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284880.pdf [firstpage_image] =>[orig_patent_app_number] => 750180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1188516 [patent_doc_number] => 06733746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-11 [patent_title] => 'Hematopoietic cell culture nutrient supplement' [patent_app_type] => B2 [patent_app_number] => 08/792299 [patent_app_country] => US [patent_app_date] => 1997-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14272 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/733/06733746.pdf [firstpage_image] =>[orig_patent_app_number] => 08792299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257351 [patent_doc_number] => 06204061 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same' [patent_app_type] => 1 [patent_app_number] => 8/781559 [patent_app_country] => US [patent_app_date] => 1997-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 12 [patent_no_of_words] => 15031 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204061.pdf [firstpage_image] =>[orig_patent_app_number] => 781559 [rel_patent_id] =>[rel_patent_doc_number] =>)